Release 5 R6 Ballot (2nd Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot2: Release 6 Ballot (2nd Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example Ingredient/example (Narrative)

Biomedical Research and Regulation Work Group Maturity Level : N/A Standards Status : Informative Compartments : No defined compartments

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile Ingredient .

Generated Narrative: Ingredient example

Resource Ingredient "example"

status : active

role : ActiveBase (ingredientRole#ActiveBase)

Manufacturers

- Manufacturer
* Organization/example Organization ACME Health

substance

Codes

- Concept
* EQUIXABAN (substance#EQUIXABAN)

strength

presentation : 50 mg (Details: UCUM code mg codemg = 'mg') /1 tablet (Details: UCUM code {tablet} code{tablet} = '{tablet}')

concentration : 5 mg (Details: UCUM code mg codemg = 'mg') /1 mg (Details: UCUM code mg codemg = 'mg')

referenceStrength

Substances

- Concept
* EQUIXABAN-SULPHATE (substance#EQUIXABAN-SULPHATE)

strength : 5.03 mg (Details: UCUM code mg codemg = 'mg') /1 mg (Details: UCUM code mg codemg = 'mg')

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.